Skip to content
  • Wednesday, 15 April 2026
  • 5:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Apr 4, 2026 0

For decades, successive waves of antidepressants have promised relief to millions suffering from mood disorders, yet the landscape for those…

Read More
Environmental & Analytical Chemistry

MRI scans show body-focused mind wandering may reduce symptoms of ADHD and depression

Abdurrohim Arsyad Apr 3, 2026 0

New research published in the Proceedings of the National Academy of Sciences on March 25 suggests that when individuals’ minds…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Mar 27, 2026 0

For decades, the medical community has grappled with the persistent challenge of mood disorders, offering successive waves of antidepressants that,…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Mar 20, 2026 0

The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…

Read More
Neuroscience & Brain Research

Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression

Rifan Muazin Mar 14, 2026 0

In a collaborative breakthrough that may redefine the clinical understanding of psychiatric disorders, researchers from the University of Queensland and…

Read More
OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disordersOxford-Led Research Unveils Revolutionary Food Supplement to Combat Honeybee DeclineLifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive DeclineUS Imposes 100% Tariff on Branded Pharmaceuticals, Sparking Industry Concerns and Geopolitical Debate
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
How to tackle the unique pharmacokinetic properties of covalent drugsLifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive DeclineResearchers at the Indian Institute of Science Observe Perfect Quantum Fluid in Graphene Breaking Fundamental Laws of PhysicsMidlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
How to tackle the unique pharmacokinetic properties of covalent drugs
Lana Keisha Apr 15, 2026
Neuroscience & Brain Research
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive Decline
Rifan Muazin Apr 15, 2026
Advanced Materials Science
Researchers at the Indian Institute of Science Observe Perfect Quantum Fluid in Graphene Breaking Fundamental Laws of Physics
Nila Kartika Wati Apr 15, 2026
Clinical Diagnostics & Pathology
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
Reynand Amr Wu Apr 15, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ